Navigation Links
Patent and Trademark Assets Related to Absorbable Surgical Adhesives and Sealants Owned by Cohera Medical Inc® to Sell on February 25, 2019 in Private Auction
Date:2/6/2019

Ocean Tomo Transactions has been retained by DCI Assignments, LLC, the Assignee of Cohera pursuant to an Assignment for the Benefit of Creditors, to conduct a private auction of the Cohera Medical Inc® absorbable surgical adhesives and sealants global patents, open applications and trademarks. The sale is by order the Chancery Court for the State of Delaware.

Subject to any approval that may be required by the Chancery Court for the State of Delaware in connection with the Assignment for the Benefit of Creditors of Cohera®, the highest bid as of February 25, 2019 (Midnight, PST) in the private auction, will acquire the intellectual property assets for the formulation, delivery device and methods covered by the Cohera surgical adhesive and sealants intellectual property.

Marketed by Cohera under the trade name TissuGlu®, the practice of the art disclosed in the patents resulted in the first 100% synthetic internal surgical adhesive approved for sale in the United States. TissuGlu, designed to meet a surgeon’s need for a strong, biocompatible and easy-to-use surgical adhesive, is an alternative to the use of postoperative fluid collection drains in mastectomy surgeries. It was also approved in the US for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty; TissuGlu passed all bio-compatibility testing as a Class III permanent implant.

With the market for surgical drains projected to rise from it’s estimated 2018 value of $1.90 billion USD to an estimated value of $2.64 billion USD by 2026, the acquirer of this portfolio of issued patents, pending applications and trademarks will have intellectual property assets with both early priority dates and important open applications in the areas of hydrophilic adhesives, pressure sensitive adhesives, spray and drop dispenser technologies.

In March of 2018, Cohera submitted a Premarket Approval Application (PMA) supplement to the U.S. Food and Drug Administration (FDA) for TissuGlu Surgical Adhesive providing new clinical evidence supporting a review by the FDA to expand the indication for TissuGlu in the US for mastectomy, pressure ulcer and other breast procedures with a combined addressable market exceeding $1 billion USD.

For further details on the portfolio, the private auction or to request an NDA for further access to a confidential presentation on this portfolio, contact Dean Becker, DeanBecker@OTI.com or +1-251-262-0000 (PST).

About Ocean Tomo

Ocean Tomo, the Intellectual Capital Merchant Banc™ firm provides companies with financial services related to intellectual property and intangible assets.
Collectively, Ocean Tomo professionals have:

  • Executed over 1000 engagements involving IP worth in excess of $10 billion;
  • Successfully closed transactions where disruptive technology played a key role, with cumulative value in excess of $750 million;
  • Conducted over 300 valuation engagements and 500 financial damages expert testimony engagements.

Ocean Tomo assists clients – corporations, law firms, governments and institutional investors – in realizing Intellectual Capital Equity®value broadly defined.

About DSI

Development Specialists, Inc. (DSI) is one of the leading providers of management consulting and financial advisory services, including turnaround consulting, financial restructuring, litigation support and forensic accounting. Our clients include business owners, private-equity investors, corporate boards, financial institutions, secured lenders, bondholders and unsecured creditors. For almost 40 years, DSI has been guided by a single objective: maximizing value for all stakeholders. With our highly skilled and diverse team of professionals, offices in the U.S. and international affiliates, and an unparalleled range of experience, DSI not only achieves that objective, but has also built a solid reputation as an industry leader.

Read the full story at https://www.prweb.com/releases/patent_and_trademark_assets_related_to_absorbable_surgical_adhesives_and_sealants_owned_by_cohera_medical_inc_to_sell_on_february_25_2019_in_private_auction/prweb16084779.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Compound Solutions Aggressively Pursues Patent Violators of its goBHB® ketone
2. Metrasens Acquires New Patents to Further Protect Its Innovative Technology
3. World’s First Chocolate Patent for Weight and Cholesterol Management Granted in Europe
4. Kalypso Wellness Centers Moves to Secure Patent for Ketamine Treatments
5. LifeWIRE in the top 10 health related patents recognized for innovation and global impact by ACT: THE APP ASSOCIATION
6. CellMax Life Blood Testing Platform for Early Cancer Detection Granted Six U.S. Patents
7. Lilly Reaches Settlement Agreement in U.S. Cialis Patent Litigation
8. Oramed Granted Canadian Patent for GLP-1 Analog Capsule
9. Vivify Health Awarded Patent for Extending EMRs with Digital Health
10. Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigation
11. Patent Case of Carl Zeiss Meditec AG and VSY Biotechnology B.V.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2019)... ... 10, 2019 , ... Thumb sucking is natural for infants and toddlers and ... age, but past that the habit can contribute to dental problems. Grover Beach ... when to intervene and help their child stop the habit. , Sucking is a ...
(Date:8/9/2019)... ... 09, 2019 , ... Dr. Austin Cope joined Tucson’s premier ... biology from Dixie State University in St. George, Utah. He earned an MBA from ... from Texas Tech University Health Sciences Center. He completed an internship at Tucson Medical ...
(Date:8/9/2019)... ... August 08, 2019 , ... Isagenix International ... announced its second round of Canada finalists for its annual total-body transformation program, ... of Selwyn, Ontario; Dwight Hodel of Medicine Hat, Alberta; Jennifer Bounds of Fort ...
Breaking Medicine Technology:
(Date:8/17/2019)... ... August 17, 2019 , ... Inc. ... Private Companies—the Inc. 5000 , For the 2nd Year In a Row, YellowTelescope ... of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC (YellowTelescope, SEOversite, ...
(Date:8/16/2019)... MANHEIM, Pa. (PRWEB) , ... August 16, 2019 ... ... of other construction safety professionals from throughout the Mid-Atlantic and North East at ... two-day interactive forum was engineered to build on existing construction safety concepts and ...
(Date:8/15/2019)... ... , ... Jon O'Brien, president of Catholics for Choice, issued ... written assurance that they will comply with the Trump Administration’s domestic gag rule ... new policy restricts providers and clinics that receive federal Title X funds. Clinics ...
(Date:8/14/2019)... ... August 15, 2019 , ... R3 Stem Cell announced this ... Cell International is offering regenerative procedures with mesenchymal stem cells performed by highly ... only $2950, which includes a complete IV therapy or two joint injections. Patients ...
(Date:8/14/2019)... ... August 14, 2019 , ... While it is commonly ... their food and beverage choices can help them manage and, in some cases, reverse ... finds that about a quarter of U.S. adults are trying to manage a health ...
Breaking Medicine News(10 mins):